ZymoGenetics stings Bristol-Myers Squibb with patent lawsuit
Seattle drug firm ZymoGenetics has taken Bristol-Myers Squibb (BMS) to court for infringement of its fusion protein technology patents by several products, including arthritis medication Orencia (abatacept).